BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24325630)

  • 1. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.
    Sawant RR; Jhaveri AM; Koshkaryev A; Zhu L; Qureshi F; Torchilin VP
    Mol Pharm; 2014 Feb; 11(2):375-81. PubMed ID: 24325630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy.
    Sawant RR; Jhaveri AM; Koshkaryev A; Qureshi F; Torchilin VP
    J Drug Target; 2013 Aug; 21(7):630-8. PubMed ID: 23594094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
    Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
    Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
    Muddineti OS; Kumari P; Ghosh B; Biswas S
    Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.
    Zou W; Sarisozen C; Torchilin VP
    J Drug Target; 2017 Mar; 25(3):225-234. PubMed ID: 27616277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
    Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
    Sarisozen C; Abouzeid AH; Torchilin VP
    Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin-anchored poly(lactide) based micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids.
    Kumari P; Rompicharla SVK; Muddineti OS; Ghosh B; Biswas S
    Int J Biol Macromol; 2018 Sep; 116():1196-1213. PubMed ID: 29753013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
    Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
    Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.
    Peng H; Jin H; Zhuo H; Huang H
    Oncotarget; 2017 Jul; 8(28):45597-45611. PubMed ID: 28484093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
    Gao W; Ye G; Duan X; Yang X; Yang VC
    Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
    Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
    Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
    Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
    Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
    Liu K; Dai L; Li C; Liu J; Wang L; Lei J
    Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
    Wu H; Yao L; Mei J; Li F
    Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.